132 related articles for article (PubMed ID: 22449371)
1. Infections in hematological malignancies.
Khayr W; Haddad RY; Noor SA
Dis Mon; 2012 Apr; 58(4):239-49. PubMed ID: 22449371
[No Abstract] [Full Text] [Related]
2. [Susceptibility to infection after splenectomy for hematologic disease. Is antipneumococcal vaccination and antibiotic prophylaxis needed?].
Gulías Piñeiro A; Fraguela Mariña J; Fernández Balnco C; Gómez Freijoso C
Sangre (Barc); 1997 Jun; 42(3):259-60. PubMed ID: 9381281
[No Abstract] [Full Text] [Related]
3. The appropriate use of antibiotics in surgery: a review of surgical infections.
Hedrick TL; Smith PW; Gazoni LM; Sawyer RG
Curr Probl Surg; 2007 Oct; 44(10):635-75. PubMed ID: 18021817
[No Abstract] [Full Text] [Related]
4. Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies.
Chee L; Brown M; Sasadeusz J; MacGregor L; Grigg AP
J Infect; 2008 Apr; 56(4):227-33. PubMed ID: 18342947
[TBL] [Abstract][Full Text] [Related]
5. Totally implantable central venous access devices in children with hemato-oncologic malignancies: evaluation of complications and comparison of incidence of febrile episodes with similar patients without central venous access devices.
Sarper N; Zengin E; Corapçioglu F; Tugay M
Pediatr Hematol Oncol; 2006 Sep; 23(6):459-70. PubMed ID: 16849276
[TBL] [Abstract][Full Text] [Related]
6. Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter.
Jaeger K; Zenz S; Jüttner B; Ruschulte H; Kuse E; Heine J; Piepenbrock S; Ganser A; Karthaus M
Ann Hematol; 2005 Apr; 84(4):258-62. PubMed ID: 15549302
[TBL] [Abstract][Full Text] [Related]
7. [Prevention of bacterial and fungal infections in neutropenic patients with malignant hematologic diseases].
Candoni A; Russo D; Salmaso F
Clin Ter; 1997; 148(1-2):23-8. PubMed ID: 9377834
[TBL] [Abstract][Full Text] [Related]
8. [Empirical antimicrobial therapy in a patient with neutropenia].
Anttila VJ; Ruotsalainen E
Duodecim; 2002; 118(21):2241-7. PubMed ID: 12486961
[No Abstract] [Full Text] [Related]
9. Sphingomonas paucimobilis bacteremia related to intravenous human immunoglobulin injections.
Lanoix JP; Hamdad F; Borel A; Thomas D; Salle V; Smail A; El Samad Y; Schmit JL
Med Mal Infect; 2012 Jan; 42(1):37-9. PubMed ID: 22075255
[No Abstract] [Full Text] [Related]
10. [Evaluation of antibiotic prophylaxis in neutropenic patients with hematologic malignancies].
Delarive P; Baumgartner JD; Glauser MP; Cometta A
Schweiz Med Wochenschr; 2000 Dec; 130(48):1837-44. PubMed ID: 11132527
[TBL] [Abstract][Full Text] [Related]
11. Treatment of patients with hematologic neoplasm, fever, and neutropenia.
Sepkowitz KA
Clin Infect Dis; 2005 Apr; 40 Suppl 4():S253-6. PubMed ID: 15768331
[TBL] [Abstract][Full Text] [Related]
12. The feasibility of early discharge with oral antimicrobial therapy in low risk patients with febrile neutropenia following chemotherapy for hematologic malignancies.
Cordonnier C
Haematologica; 2006 Feb; 91(2):150a. PubMed ID: 16461296
[No Abstract] [Full Text] [Related]
13. [Clinical and epidemiological features of infections in the neutropenic patient].
Viscoli C; Castagnola E
Haematologica; 1989 Oct; 74(5 Suppl):287-96. PubMed ID: 2512215
[No Abstract] [Full Text] [Related]
14. Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients.
Baskaran ND; Gan GG; Adeeba K
Ann Hematol; 2008 Jul; 87(7):563-9. PubMed ID: 18437382
[TBL] [Abstract][Full Text] [Related]
15. [Febrile neutropenia].
Tamura K
Rinsho Ketsueki; 2007 Apr; 48(4):273-84. PubMed ID: 17515117
[No Abstract] [Full Text] [Related]
16. Clinical and microbiological effects of biapenem in febrile neutropenic patients with hematologic malignancies.
Isobe Y; Kanemitsu N; Yahata Y; Masuda A; Tsukune Y; Sugimoto K
Scand J Infect Dis; 2009; 41(3):237-9. PubMed ID: 19116887
[No Abstract] [Full Text] [Related]
17. Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies.
Chong Y; Yakushiji H; Ito Y; Kamimura T
Int J Infect Dis; 2011 Apr; 15(4):e277-81. PubMed ID: 21324723
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of prevention of catheter-related bloodstream infection by continuous infusion of low-dose unfractionated heparin in patients with hematologic and oncologic disease.
Abdelkefi A; Torjman L; Ladeb S; Othman TB; Achour W; Lakhal A; Hsairi M; Kammoun L; Hassen AB; Abdeladhim AB
J Clin Oncol; 2005 Nov; 23(31):7864-70. PubMed ID: 16258088
[TBL] [Abstract][Full Text] [Related]
19. A sixty-five-year-old female with pneumonia, endocarditis and meningitis.
Fazili T; James O; Wani L
J Okla State Med Assoc; 2009 Aug; 102(8):269-70. PubMed ID: 19750817
[No Abstract] [Full Text] [Related]
20. Central venous catheter-associated bloodstream infection and colonisation of insertion site and catheter tip. What are the rates and risk factors in haematology patients?
Luft D; Schmoor C; Wilson C; Widmer AF; Bertz H; Frei R; Heim D; Dettenkofer M
Ann Hematol; 2010 Dec; 89(12):1265-75. PubMed ID: 20532506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
